Regular Article
Inhibitory Effect of Zinc on the Absorption of JBP485 via the Gastrointestinal Oligopeptide Transporter (PEPT1) in Rats

https://doi.org/10.2133/dmpk.DMPK-11-RG-014Get rights and content

Summary:

The aim of this study was to investigate the pharmacokinetic mechanism of interaction between JBP485 and zinc. The plasma concentration of JBP485 after oral administration in vivo, the plasma concentration of JBP485 from the portal vein after jejunal perfusions in situ, the serosal fluid concentration of JBP485 in everted small intestine preparations and the uptake of JBP485 by HeLa-hPEPT1 cells in vitro were determined by LC-MS/MS. RT-PCR and Western blotting were used to determine the mRNA and protein levels of Pept1 in the intestinal mucosa. The AUCs of JBP485 in in vivo, in vitro and in situ studies were significantly decreased after zinc pre-administration. Kinetic analysis showed that zinc inhibits the uptake of JBP485 by decreasing the affinity of JBP485 for PEPT1 in HeLa-hPEPT1 cells. RT-PCR and Western blotting indicated that zinc had no effect on basal intestinal Pept1 expression. Our results are novel in demonstrating for the first time that zinc ions, but not zinc gluconate, can inhibit the transport activity of PEPT1. In addition, the uptake of JBP485 was not affected by changes in pH values after zinc treatment. Zinc decreases the absorption of JBP485 by inhibiting the transport activity of PEPT1; however, basal intestinal Pept1 expression does not change.

References (33)

  • M.E. Ganapathy et al.

    Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2

    Biochem. Biophys. Res. Commun.

    (1998)
  • T. Terada et al.

    Interaction of β-lactam antibiotics with histidine residue of rat H +/Peptide cotransporters, PEPT1 and PEPT2

    J. Biol. Chem.

    (1998)
  • X.Z. Chen et al.

    Functional roles of histidine and tyrosine residues in the H+ -peptide transporter PepT1

    Biochem. Biophys. Res. Commun.

    (2000)
  • N.W. Solomons

    Biological availability of zinc in humans

    Am. J. Clin. Nutr.

    (1982)
  • F.H. Leibach et al.

    Peptide transporters in the intestine and the kidney

    Annu. Rev. Nutr.

    (1996)
  • K. Inui et al.

    Dipeptide transporters

  • Cited by (14)

    • PTR2/POT/NPF transporters: what makes them tick?

      2021, Advances in Protein Chemistry and Structural Biology
      Citation Excerpt :

      The transport and uptake of antimetabolite drug floxuridine was shown to be enhanced upon conjugation with dipeptides (Phe-Gly, Phe-Tyr and Ile-Gly) (Tsume, Hilfinger, & Amidon, 2008). Generally, cyclic peptides are low affinity and poor substrates for PepT1 such as JP845 (Miao et al., 2011). Pseudo-tripeptidization of JP485 improved the transport and affinity toward PEPT1 (Jiang et al., 2019).

    • Dioscin protects against ANIT-induced cholestasis via regulating Oatps, Mrp2 and Bsep expression in rats

      2016, Toxicology and Applied Pharmacology
      Citation Excerpt :

      Then, dioscin uptake study using isolated rat hepatocytes indicated that compared to control group, the Vmax value was decreased, without affecting Km in ANIT-induced cholestasis (Fig. 3C). As we know, Km value represents the transport function of transporter, while Vmax value means the expression of transporter (Ashida et al., 2004; Miao et al., 2011). In other words, the reduction of Vmax value for dioscin indicated the expression of Oatps might be decreased in ANIT-induced cholestasis.

    • Intestinal drug transporters: An overview

      2013, Advanced Drug Delivery Reviews
    • OAT1 and OAT3: Targets of drug-drug interaction between entecavir and JBP485

      2013, European Journal of Pharmaceutical Sciences
      Citation Excerpt :

      JBP485 (cyclo-trans-4-L-hydroxyprolyl-L-serine) is one type of dipeptide, and animal experiments have demonstrated that JBP485 exhibits a liver protective effect via oral administration (Liu et al., 2000; Yang et al., 2009; Wu et al., 2008). Our previous studies have shown that JBP485 is a substrate of OAT1, OAT3 (Zhang et al., 2010; Zhu et al., 2012; Guo et al., 2012a,b; Ye et al., 2012), and PEPT1 (Guo et al., 2012a,b; Cang et al., 2010; Liu et al., 2011; Miao et al., 2011). Owing to the complex pathology, the treatment programs for hepatitis B not only work on against hepatitis B virus, but also need to protect liver cells.

    • Inhibitory effect of 1α,25-dihydroxyvitamin D<inf>3</inf> on excretion of JBP485 via organic anion transporters in rats

      2013, European Journal of Pharmaceutical Sciences
      Citation Excerpt :

      The substrates of Oat1 include various drugs, such as p-Aminohippurate (PAH), antiviral drugs, β-lactam antibiotics, anti-inflammatory agents, methotrexate and endogenous organic anions, whereas the major substrates of Oat3 include benzylpenicillin (PCG), cimetidine, estrone sulfate, pravastatin, and ochratoxin A (Deguchi et al., 2004; Uwai et al., 1998). JBP485 (cyclo-trans-4-L-hydroxyprolyl-L-serine) is a dipeptide (Liu et al., 2000) that was first isolated from Laennec (a trade name for the hydrolysate of human placenta), and has been synthesized by chemical means (Miao et al., 2011). Animal experiments have indicated that JBP485 exhibits obvious liver (Liu et al., 1998; Wu et al., 2008; Yang et al., 2009) and gastrointestinal (Wang et al., 2011) protective effects.

    • Benzylpenicillin inhibits the renal excretion of acyclovir by OAT1 and OAT3

      2013, Pharmacological Reports
      Citation Excerpt :

      All experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. In all cases, we used diethyl ether to anesthetize the rats [15]. Acyclovir and PCG were soluble in normal saline or buffer solution and were administered intravenously via the jugular vein to rats in aqueous solution.

    View all citing articles on Scopus
    View full text